<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> DOE1-03-0729 </DOCNO><TEXT>This patent describes a process for reducing tissue damage due to radiotherapyin a warm-blooded animal to be subjected to such therapy. It consistsof administering to the warm-blooded animal (a) at least one member selectedfrom the group consisting of 5-methyl-3-sulfanilamidoisoxazole and asalt of 5-methyl-3-sulfanilamidoisoxazole with a pharmaceutically acceptablebase, and (b) at least one member selected from the group consistingof 2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine and a salt of 2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine with a pharmaceutically acceptable acid, the (a) and (b) beingadministered in an amount effective to reduce tissue damage.</TEXT></DOC>